Exercise-facilitated Neurorehabilitation in Diabetic Neuropathy

Study Description

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

This study will determine the type and combination of exercise needed to rehabilitate the neuro-compromised diabetic Veteran. Guided exercise protocols may prove to be practical therapeutic options for the prophylactic management of diabetic subjects with neuropathy.

Condition or disease	Intervention/treatment	Phase
Diabetic Neuropathy	Behavioral: Exercise	Not Applicable

Detailed Description:

Purpose: A single-site, randomized, blinded, prospective clinical trial is proposed to determine the significance of a combined isokinetic strength and aerobic exercise training program on the rehabilitation of peripheral nerve function in Type 2 diabetic veterans and non-veterans with neuropathy. Background and Significance: Obesity is a major factor in the increasing rates of diabetes and its related complications. Diabetes affects greater than 7% of the population. Veterans are at even greater risk, with approximately 16% currently receiving treatment at Department of Veterans Affairs Medical Centers for diabetes. More than half of affected veterans experience debilitating complications of diabetes, including peripheral neuropathy (PN). Exercise training, in combination with pharmacologic intervention, is now recognized as a cornerstone of management for diabetes. Therapeutic interventions currently available for the treatment of PN in diabetic patients are limited, however, to pain management and stringent glycemic control. Exercise is reported to significantly decrease peripheral nerve microvascular complications common among chronic diabetics. Our preliminary findings demonstrate that exercise intervention improves peripheral nerve function in the diabetic veteran with PN. Intervention strategies, such as proposed in this application, offer a unique and novel therapeutic option for the rehabilitation of the neuro-compromised Type 2 diabetic veterans and non-veterans. Methods & Research Plan: One-hundred subjects will be recruited for this 24-week study. Subjects each will be randomly assigned to aerobic, isokinetic strength training, combined aerobic and strength training, or non-exercise (control) intervention groups. Isokinetic strength training (Biodex System 3), aerobic exercise training (treadmill), or the combination of strength and aerobic training will be administered 3x per week for the initial 12 weeks. Control subjects will receive 12 clinical visits over the course of the initial 12 weeks. The effects of exercise training type, compared with control subjects, on recovery of peripheral nerve function will be rigorously determined from baseline, 12- and 24-week testing using electrodiagnostic primary outcome measures, Quantitative Sensory Testing, and a battery of validated qualitative and quantitative secondary outcome measures that include an incremental symptom-limited treadmill test, peak torque, Total Neuropathy Score, visual analogue pain scale, and quality of life SF-36V Health Survey. Sustainability of effect will be determined at 24-weeks.The individual effects of exercise training type, compared with control subjects, on tissue oxygenation will be determined from baseline, 12- and 24-week testing by non-invasive quantitated infrared spectroscopy using an InSpectraTM Tissue Spectrometer. Expected Outcomes: This study will objectively and critically determine the type and combination of exercise needed to rehabilitate the neuro-compromised diabetic Veteran. Guided exercise protocols may prove to be practical therapeutic options for the prophylactic management of diabetic subjects with neuropathy.

Study Design

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	100 participants
Allocation:	Randomized
Intervention Model:	Factorial Assignment
Masking:	Single (Investigator)
Primary Purpose:	Treatment
Official Title:	Exercise-Facilitated NeuroRehabilitation in Diabetic Neuropathy
Study Start Date :	December 2009
Actual Primary Completion Date :	November 2014
Estimated Study Completion Date :	December 2016

Arms and Interventions

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm	Intervention/treatment
No Intervention: Arm 1; Sedentary Control Group
Experimental: Arm 2; Aerobic Exercise Group	Behavioral: Exercise; Structured aerobic exercise (treadmill).
Experimental: Arm 3; Isokinetic Strength Exercise Group	Behavioral: Exercise; Structured isokinetic strength exercise (dynameter).
Experimental: Arm 4; Combined Aerobic and Isokinetic Strength Exercise Group	Behavioral: Exercise; Structured aerobic exercise (treadmill). Behavioral: Exercise; Structured isokinetic strength exercise (dynameter).

Outcome Measures

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. Electrodiagnostic [ Time Frame: Initial entry into study, 12 and 24 weeks ]

Secondary Outcome Measures :

1. aerobic capacity [ Time Frame: Initial entry into study, 12 and 24 weeks ]
2. quality of life, including pain perception and health care [ Time Frame: Initial entry into study, 12 and 24 weeks ]
3. isokinetic peak torque [ Time Frame: Initial entry into study, 12 and 24 weeks ]
4. tissue oxygen saturation [ Time Frame: Initial entry into study, 12 and 24 weeks ]

Eligibility Criteria

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	45 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

• Clinical diagnosis of type 2 diabetes mellitus
• stable blood glucose control
• clinical findings consistent with length-dependent sensorimotor polyneuropathy, stage N2a

Exclusion Criteria:

• foot ulceration
• unstable heart disease
• co-morbid conditions limiting exercise
• disorders of the central nervous system causing weakness or sensory loss
• received treatment with medications known to have neuropathy as a prominent side effect including vincristine, vinblastine, cis-platin, and paclitaxel
• medical conditions that may be associated with neuropathies such as alcoholism, liver disease, kidney disease, toxic exposure, vitamin deficiency, autoimmune disorders, cancer, or hypothyroidism

Contacts and Locations

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Locations

United States, Illinois
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, United States, 60141-5000

Sponsors and Collaborators

VA Office of Research and Development

Investigators

Principal Investigator:	Evan Stubbs	Edward Hines Jr. VA Hospital, Hines, IL

More Information

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party:	VA Office of Research and Development
ClinicalTrials.gov Identifier:	NCT00955201 History of Changes
Other Study ID Numbers:	B6954-R; 1I01RX000130-01 ( U.S. NIH Grant/Contract )
First Posted:	August 10, 2009
Last Update Posted:	April 13, 2015
Last Verified:	April 2015

Keywords provided by VA Office of Research and Development:

diabetes mellitus; diabetic neuropathies; Aerobic Exercise	Exercise Therapy; electromyography; United States Veterans

Additional relevant MeSH terms:

Peripheral Nervous System Diseases; Diabetic Neuropathies; Neuromuscular Diseases; Nervous System Diseases	Diabetes Complications; Diabetes Mellitus; Endocrine System Diseases